Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
09/2006
09/19/2006US7109380 Oxymethylidene-substituted, e.g., 2-(1-methoxy-ethylidene)-cyclopent-4-ene-1,3-diones; inhibit fluconazole-resistant C. albicans strains; may be used for the treatment of life-threatening candidiasis associated with immunocompromised patients.
09/19/2006US7109244 Animal extract; antitumor agents; anticancer agents
09/14/2006US20060205821 Enantiomers of N-desmethyl venlafaxine
09/14/2006DE102005009134A1 Biologisch abbaubare Gashydratinhibitoren Biodegradable gas hydrate
09/13/2006CN1832761A Thiotungstate analogues and uses thereof
09/13/2006CN1832733A Deramciclane-fumarate tablets
09/13/2006CN1830951A Method for preparing (+-)-alpha-[(substituted amino) methyl]-benzene ring substituted group-phenylmethanol type compounds
09/13/2006CN1275101C Electric photographic photoreceptor, imaging processing cartidge and electric photographic device
09/12/2006US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers
09/12/2006US7105574 Composition of GAP DMORIE and colipids; adjuvant of cytofectin and neutral lipid such as a phosphatidylethanolamine provide elevation of antibody levels particularly in applications where antibody levels from the immunogen-encoding polynucleotide alone are sub-optimal
09/08/2006WO2006093014A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
09/08/2006CA2599331A1 Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals preparation comprising the same
09/07/2006US20060199861 Methods of using derivatives of (-)-venlafaxine
09/07/2006US20060199860 Salts of (-)-O-desmethylvenlafaxine
09/07/2006US20060199848 Ion channel modulating activity II
09/06/2006EP1698631A1 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery
09/06/2006EP1698615A1 Method of obtaining tolterodine
09/06/2006EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
09/06/2006EP1697299A2 Processes for preparing venlafaxine and venlafaxine hydrochloride of form i
09/06/2006CN1829681A Process for the preparation of substituted 3-aryl-butylamine compounds
09/06/2006CN1827733A Organic electroluminescence device
09/06/2006CN1827586A Process for preparing 4,4'-diamino diphenyl ether
09/05/2006US7101915 P-terphenyl compounds
09/05/2006US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/05/2006US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents
09/05/2006US7101632 Cyclocondensed polycyclic hydrocarbon compound and light-emitting device using the same
08/2006
08/31/2006WO2006089708A1 Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride
08/31/2006WO2006089707A1 Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds
08/31/2006US20060194988 Process for the preparation of substitued 3-aryl-butylamine compounds
08/31/2006DE102005009217A1 New phosphoric acid salts of 6-dimethylaminomethyl -1-(3-methoxyphenyl)-1,3-dihydroxycyclohexane useful to treat e.g. pain, migraine, depressions, neurodegenerative illnesses, cognitive illnesses, fear conditions and epilepsy
08/31/2006CA2598845A1 Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl)-1,3-dihydr oxy-cyclohexane compounds
08/31/2006CA2598579A1 Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride
08/30/2006EP1695957A1 Crystalline forms of (1RS,3RS,6RS)-6-Dimethylaminomethyl-1-(3-methoxy-phenyl)cyclohexane-1,3-diol hydrochloride
08/30/2006EP1694742A1 Modified alkoxylated polyol compounds
08/30/2006EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
08/30/2006EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
08/30/2006EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives
08/30/2006CN1826308A Fluorocombretastatin and derivatives thereof
08/29/2006US7098365 [4-{2-[(2-hydroxy-benzylidene)-amino]-ethyl}-phenol]; plant growth regulator
08/29/2006US7098364 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis
08/29/2006CA2212856C Benzopyran-containing compounds and method for their use
08/24/2006WO2006088525A1 Synthetic process for aminocyclohexyl ether compounds
08/24/2006WO2006063829A3 Methamphetamine derivatives and conjugates for immunoassay
08/24/2006CA2586925A1 Synthetic process for aminocyclohexyl ether compounds
08/23/2006EP1692093A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/23/2006EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist
08/23/2006CN1821215A Fluorine containing asymmetric aromatic ether diamine and preparation and use thereof
08/23/2006CN1821214A Corrosion inhibitors comprising nitrogen functionality
08/23/2006CN1821212A Synthetic method for dapoxetine
08/23/2006CN1821190A Purifying method of (r)-n-(3,4-dimethoxy benzyl)-1-phenylethylamine l-tartrate and purifying method of (r)-n-(3,4-dimethoxy benzyl)-1-phenylethylamine
08/23/2006CN1271167C Organic electroluminescent element
08/23/2006CN1271114C Oxalkylation products produced from expoxides and amines and their use in pigment preparations
08/18/2006CA2535667A1 A process for the preparation of tolterodine
08/17/2006WO2006085493A1 Aromatic diamine and process for producing the same
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/17/2006US20060183806 Compositions and methods comprising long-chain, straight-chain 2-amino-3- hydroxyalkanes
08/16/2006EP1191019B1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1819989A 2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof
08/16/2006CN1817851A N-substituted-w-amino-1,2,3,4-tetrahydronaphthalene compounds with antifungal activity and their salts
08/16/2006CN1269798C Producing procedure of 3,4'-diamino diphenyl ether
08/16/2006CN1269797C Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same
08/16/2006CN1269793C Method for producing 3,3-diarylpropylamines
08/15/2006US7091240 Destroying tumor cell vasculation; antitumor agents; anticancer agents
08/15/2006CA2266488C Selective alkylation of an alcohol substituted phenol compound
08/10/2006US20060178522 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof
08/10/2006US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists
08/09/2006EP1687255A2 Calixarenes as inhibitors of protein kinase b
08/09/2006EP1687254A2 Process for the optical resolution and recycling of tomoxetine
08/09/2006EP1687253A2 Diphenylamine derivatives
08/08/2006US7087799 Such as 2,2'-methylenebis(4-methyl-6-hydroxymethylphenol) for production of photosensitive polyimides
08/08/2006US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/08/2006US7087310 condesation of a 4-(N,N-diarylamino)benzaldehyde with a 2,6-naphthyl diphosphonic ester or 2,6-diphosphonium naphthalene; electroluminescent electron or hole transfer layer emitts yellow or red light
08/03/2006WO2006032893A3 Trityl derivatives for enhancing mass spectrometry
08/03/2006US20060173204 New 3-aryl propionic acid derivatives and analogs
08/03/2006US20060173035 3-Aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
08/02/2006EP1685091A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
08/02/2006EP1001785B1 Use of colchinol derivatives as vascular damaging agents
08/02/2006EP0970935B1 Method of separating optical isomers
08/01/2006US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders
08/01/2006US7083862 Dendrimers
08/01/2006CA2269217C New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives
07/2006
07/27/2006WO2004064762A9 Novel cocrystallization
07/27/2006US20060167318 Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)- amine compounds by heterogeneous catalysis
07/27/2006US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin
07/27/2006US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
07/27/2006US20060166103 Quaternary ammonium salts
07/27/2006DE102005003634A1 Triarylamin-Derivate II mit raumfüllenden Seitengruppen und Verwendung in elektrolumineszenten und elektrofotografischen Vorrichtung Triarylamine derivatives II with room-filling side groups and use in electroluminescent and electrophotographic apparatus
07/26/2006EP1682513A1 Method for producing cyclic, n-substituted alpha-iminocarboxylic acids
07/26/2006EP1682486A1 Quaternary amino-functional chalcones
07/26/2006EP1682485A2 Enantiomerically pure atomoxetine and tomoxetine mandelate
07/26/2006EP1682484A1 Omega-substituted-naphthyloxyalklamino derivatives as antihyperglycemic agents and preparation
07/26/2006EP1682081A2 Process for manufacture of metoprolol and salts thereof
07/26/2006EP1532089A4 Fluorene compound and organic luminescent device using the same
07/26/2006EP1368299B1 Substituted c-cyclohexylmethylamine derivatives
07/26/2006CN1809527A Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)- amine compounds by heterogeneous catalysi
07/26/2006CN1807399A Method for preparing 4,4'-diaminodiphenyl ether
07/26/2006CN1266116C Preparing method of venlafaxine and its salt
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 140